Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Expand chart
Data: CSSE Johns Hopkins University; Map: Andrew Witherspoon/Axios

The number of new coronavirus infections in the U.S continues to rise, making a quick, clean end to the pandemic less and less likely.

The big picture: Much of the U.S. is relying almost exclusively on vaccines to control the virus, abandoning social distancing and other safety measures. And that’s helping the virus to steadily gain ground even as vaccinations barrel ahead.

By the numbers: The U.S. averaged roughly 71,000 new cases per day over the past week. That’s about a 9% jump over the daily average from the week before.

  • The number of new cases rose over the past week in 25 states, and only declined in six.

Why it matters: Another surge in cases is likely to be a lot less deadly than previous waves, because so many vulnerable Americans have been vaccinated. But it will provide fertile conditions for the virus to continue mutating into new variants, keeping the coronavirus in our lives even longer.

The bottom line: The less you do to control the coronavirus, the harder it becomes to control the coronavirus in the future.

Each week, Axios tracks the change in new infections in each state. We use a seven-day average to minimize the effects of day-to-day discrepancies in states’ reporting.

Go deeper

Updated 8 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

Bryan Walsh, author of Future
Apr 14, 2021 - Health

Why our brains struggle to understand risk

Illustration: Aïda Amer/Axios

The decision to pause the use of Johnson & Johnson's COVID-19 vaccine — and the furor that now surrounds it — underscores the confounding psychology behind risk assessment.

Why it matters: From vaccines to emerging technologies, the future will force us to make difficult, risk-based choices that our Stone Age brains are ill-equipped to handle, especially in an environment where social trust has evaporated.

Apr 14, 2021 - Health

CDC panel requests more data before making decision on J&J vaccine pause

Photo: Jakub Porzycki/NurPhoto via Getty Images

An advisory panel for the Centers for Disease Control and Prevention on Wednesday delayed making recommendations on a decision to pause the use of Johnson & Johnson's coronavirus vaccine, saying it needed more time to examine the data and possible risks, NBC News reports.

Driving the news: Researchers said they did not have enough data to analyze the potential relationship between the J&J vaccine and the rare cases of severe blood clots that six women developed within two weeks of receiving the shot. It will be at least a week before the panel reconvenes.